Scientific Considerations and Requirements for the Approval of Generic Synthetic Peptide Prefilled Syringe by Usfda.

Main Article Content

Shraddha Phatangare, Anil Khokale, Girish Kashid, Satyendra Deka, Gowtham M, Prashant Patil

Abstract

Introduction: Before drugs can be sold, they have to be proven safe and effective by law. USFDA oversees the safety of food and drugs. When it comes to approving drugs, there's a process, which includes submitting an application for generic drugs. Recently, the FDA has seen more requests for approval of generic versions of peptide medicines. Having these generic versions available is important for making sure people can access these essential medications. But, ensuring that generic versions are as good as brand-name ones can be tricky, especially for peptide drugs with specific amino acid sequences. Contaminants introduced during manufacturing can be a problem, as they might affect the safety of the generic medicine. These contaminants, which are similar to the medicine itself, can be tough to detect, analyze, and regulate. This study gives a detailed look at combination products, focusing on the scientific aspects of submitting generic versions of peptide prefilled syringes. It covers things like characterizing peptides, specifying drug substances and products, and studying impurities—all of which are important for getting approval from the FDA.  i.    Objectives: To brief about the drug device combination products and overview what are generic drug products and Abbreviated New Drug Application. To study the submission requirements of USFDA for synthetic peptides and analytical techniques used for drug characterization. Also to get a basic understanding of prefilled syringe.

Article Details

Section
Articles